APA

Badman M. K., Chen J., Desai S., Vaidya S., Neelakantham S., Zhang J., Gan L., Danis K., Laffitte B. & Klickstein L. B. (20210528). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non-Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers. : Clinical pharmacology in drug development.

Chicago

Badman Michael K, Chen Jin, Desai Sachin, Vaidya Soniya, Neelakantham Srikanth, Zhang Jie, Gan Lu, Danis Kate, Laffitte Bryan and Klickstein Lloyd B. 20210528. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non-Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers. : Clinical pharmacology in drug development.

Harvard

Badman M. K., Chen J., Desai S., Vaidya S., Neelakantham S., Zhang J., Gan L., Danis K., Laffitte B. and Klickstein L. B. (20210528). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non-Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers. : Clinical pharmacology in drug development.

MLA

Badman Michael K, Chen Jin, Desai Sachin, Vaidya Soniya, Neelakantham Srikanth, Zhang Jie, Gan Lu, Danis Kate, Laffitte Bryan and Klickstein Lloyd B. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Non-Bile Acid FXR Agonist Tropifexor (LJN452) in Healthy Volunteers. : Clinical pharmacology in drug development. 20210528.